Effect of acetate-free biofiltration with a potassium-profiled dialysate on the control of cardiac arrhythmias in patients at risk: A pilot study

Hemodialysis International

Volumn 12, Issue 1, 2008, Pages 108-113

  Muñoz, Rosa I ^a   Montenegro, Jesús ^a   Salcedo, Alberto ^a   Gallardo, Isabel ^a   Martínez, Isabel ^a   Quintanilla, Nuria ^a   Saracho, Ramón ^a   Lekuona, Iñaki ^a  

^a HOSPITAL DE GALDAKAO   (Spain)

Author keywords

Arrhythmia; Dialysis solutions chemistry; Electrocardiography; Kidney diseases therapy; Potassium

Indexed keywords

ACETIC ACID; POTASSIUM;

AGED; AGING; ARTICLE; BIOFILTRATION; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIALYSATE LEVEL; DISEASE SEVERITY; ELECTROCARDIOGRAM; ELECTROLYTE BLOOD LEVEL; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE; HEART VENTRICLE EXTRASYSTOLE; HEMODIALYSIS; HEMOFILTRATION; HIGH RISK PATIENT; HUMAN; HYPERKALEMIA; HYPERTENSION; INTERMETHOD COMPARISON; MALE; PATIENT SAFETY; PILOT STUDY; POTASSIUM BLOOD LEVEL; QT INTERVAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEQUENTIAL ANALYSIS; TREATMENT DURATION; VALVULAR HEART DISEASE; BIOFILTER; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; DIALYSATE; DISEASE CONTROL; ELECTROCARDIOGRAPHY;

AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; FEMALE; HEART RATE; HEMODIAFILTRATION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PILOT PROJECTS; POTASSIUM; RENAL DIALYSIS; RISK FACTORS; SAFETY;

EID: 39149094272     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2008.00250.x     Document Type: Article

References (15)

1. Collins AJ, Kasiske B, Herzog C, et al. Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis. 2007; 49(Suppl 1):S1-S296.
2. Meier P, Vogt P, Blanc E. Ventricular arrhythmias and sudden cardiac death in end-stage renal disease patients on chronic hemodialysis. Nephron. 2001; 87:199-214.
3. Redaelli B, Locatelli F, Limido D, et al. Effect of a new model of hemodialysis potassium removal on the control of ventricular arrhythmias. Kidney Int. 1996; 50:609-617.
4. Floccari F, Aloisi E, Nostro L, et al. QTc interval and QTc dispersion during haemofiltration. Nephrology. 2004; 9:335-340.
5. Averbukh Z, Rosenmberg R, Galperin E, et al. Cell-associated magnesium and QT dispersion in hemodialysis patiens. Am J Kidney Dis. 2003; 41:196-202.
6. Cupisti A, Galetta F, Caprioli R, et al. Potassium removal increases the QTc interval dispersion during hemodialysis. Nephron. 1999; 82:122-126.
7. Redaelli B, Bonoldi G, Filippo G, Vigano G, Malnati A. Behaviour of potassium removal in different dialytic schedules. Nephrol Dial Transplant. 1998; 13(Suppl 6):35-38.
8. RombolàG, Colussi G, De Ferrari ME, Frontini A, Minetti L. Cardiac arrhythmias and electrolyte changes during haemodialysis. Nephrol Dial Transplant. 1992; 7:318-322.
9. Santoro A, Mancini E, Fontanazzi F, Paolini F. Potassium profiling in acetate-free biofiltration. Contrib Nephrol. 2002; 137:260-267.
10. Santoro A, Mancini E, Gaggi R, et al. Electrophysiological response to dialysis: The role of dialysate potassium content and profiling. Contrib Nephrol. 2005; 149:295-305.
11. Severi S, Vecchietti S, Cavalcanti S, Mancini E, Santoro A. Electrocardiographic changes during hemodiafiltration with different potassium removal rates. Blood Purif. 2003; 21:381-388.
12. Buemi M, Aloisi E, Coppolino G, et al. The effect of two different protocols of potassium haemodiafiltration on QT dispersion. Nephrol Dial Transplant. 2005; 20:1148-1154.
13. Lown B, Wolf M. Approaches to sudden death from coronary heart disease. Circulation. 1971; 44:130-142.
14. Genovesi S, Rivera R, Fabbrini P, et al. Dynamic QT interval analysis in uraemic patients receiving chronic haemodialysis. J Hypertension. 2003; 21:1921-1926.
15. Covic A, Diaconita M, Gusbeth-Tatomir P, et al. Haemodialysis increases QT(c) interval but not QT(c) dispersion in ESRD patients without manifest cardiac disease. Nephrol Dial Transplant. 2002; 17:2170-2177.